相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。DNA Repair Gene Polymorphisms and Benefit From Gefitinib in Never-Smokers With Lung Adenocarcinoma
Ji-Youn Han et al.
CANCER (2011)
Functional EGFR Germline Polymorphisms May Confer Risk for EGFR Somatic Mutations in Non-Small Cell Lung Cancer, with a Predominant Effect on Exon 19 Microdeletions
Wanqing Liu et al.
CANCER RESEARCH (2011)
Genetic polymorphisms of multiple DNA repair pathways impact age at diagnosis and TP53 mutations in breast cancer
Tasha R. Smith et al.
CARCINOGENESIS (2011)
Long Exposure of Environmental Tobacco Smoke Associated with Activating EGFR Mutations in Never-Smokers with Non-Small Cell Lung Cancer
Tomoya Kawaguchi et al.
CLINICAL CANCER RESEARCH (2011)
EGFR L858R Mutation and Polymorphisms of Genes Related to Estrogen Biosynthesis and Metabolism in Never-Smoking Female Lung Adenocarcinoma Patients
Shi-Yi Yang et al.
CLINICAL CANCER RESEARCH (2011)
Genetically informed lung cancer medicine
William Pao et al.
JOURNAL OF PATHOLOGY (2011)
Frequency of and variables associated with the EGFR mutation and its subtypes
Tomoaki Tanaka et al.
INTERNATIONAL JOURNAL OF CANCER (2010)
Correlation Between HLA Alleles and EGFR Mutation in Japanese Patients with Adenocarcinoma of the Lung
Hidetaka Uramoto et al.
JOURNAL OF THORACIC ONCOLOGY (2010)
Gender-related differences in response to mutagens and carcinogens
M. Kirsch-Volders et al.
MUTAGENESIS (2010)
Genomic instability - an evolving hallmark of cancer
Simona Negrini et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2010)
Interactive Effect of Cigarette Smoking With Human 8-Oxoguanine DNA N-Glycosylase 1 (hOGG1) Polymorphisms on the Risk of Lung Cancer: A Case-Control Study in Taiwan
Chin-Hao Chang et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2009)
Evaluation of a candidate breast cancer associated SNP in ERCC4 as a risk modifier in BRCA1 and BRCA2 mutation carriers. Results from the Consortium of Investigators of Modifiers of BRCA1/BRCA2 (CIMBA)
A. Osorio et al.
BRITISH JOURNAL OF CANCER (2009)
Using germline genotype in cancer pharmacogenetic studies
Sarah R. McWhinney et al.
PHARMACOGENOMICS (2009)
Soy consumption reduces the risk of non-small-cell lung cancers with epidermal growth factor receptor mutations among Japanese
Keitaro Matsuo et al.
CANCER SCIENCE (2008)
Increased prevalence of EGFR-mutant lung cancer in women and in East Asian populations:: Analysis of estrogen-related polymorphisms
Daphne W. Bell et al.
CLINICAL CANCER RESEARCH (2008)
EGFR mutant lung adenocarcinomas in patients with germline BRCA mutations
Jenifer L. Marks et al.
JOURNAL OF THORACIC ONCOLOGY (2008)
Potentially functional polymorphisms of EXO1 and risk of lung cancer in a Chinese population:: A case-control analysis*
Guangfu Jin et al.
LUNG CANCER (2008)
ERCC4 associated with breast cancer risk:: A two-stage case-control study using high-throughput genotyping
Roger Laughlin Milne et al.
CANCER RESEARCH (2006)
Influence of polymorphism in DNA repair and defence genes on p53 mutations in bladder tumours
Charlotta Ryk et al.
CANCER LETTERS (2006)
MC1R germline variants confer risk for BRAF-mutant melanoma
Maria Teresa Landi et al.
SCIENCE (2006)
Lung adenocarcinomas induced in mice by mutant EGF receptors found in human lung cancers respond to a tyrosine kinase inhibitor or to down-regulation of the receptors
Katerina Politi et al.
GENES & DEVELOPMENT (2006)
The impact of human EGFR kinase domain mutations on lung tumorigenesis and in vivo sensitivity to EGFR-targeted therapies
Hongbin Ji et al.
CANCER CELL (2006)
Gastrostomy in oropharyngeal cancer patients with ERCC4 (XPF) germline variants
DG Kornguth et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2005)
A permutation test for inference in logistic regression with small- and moderate-sized data sets
DM Potter
STATISTICS IN MEDICINE (2005)
Clinical and biological features associated with epidermal growth factor receptor gene mutations in lung cancers
H Shigematsu et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2005)
Gefitinib-sensitizing EGFR mutations in lung cancer activate anti-apoptotic pathways
R Sordella et al.
SCIENCE (2004)
EGFR mutations in lung cancer:: Correlation with clinical response to gefitinib therapy
JG Paez et al.
SCIENCE (2004)
Epidermal growth factor receptor in non-small-cell lung carcinomas:: Correlation between gene copy number and protein expression and impact on prognosis
FR Hirsch et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
A potential role for the estrogen-metabolizing cytochrome P450 enzymes in human breast carcinogenesis
F Modugno et al.
BREAST CANCER RESEARCH AND TREATMENT (2003)
DNA mismatch repair and mutation avoidance pathways
TM Marti et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2002)
Genome maintenance mechanisms for preventing cancer
JHJ Hoeijmakers
NATURE (2001)
Gender difference in DNA adduct levels among nonsmoking lung cancer patients
YW Cheng et al.
ENVIRONMENTAL AND MOLECULAR MUTAGENESIS (2001)
NAD(P)H:quinone oxidoreductase 1 (NQO1):: chemoprotection, bioactivation, gene regulation and genetic polymorphisms
D Ross et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2000)
A common polymorphism acts as an intragenic modifier of mutant p53 behaviour
MC Marin et al.
NATURE GENETICS (2000)
分享论文
